Printer Friendly

MERIS LABS' FORMER PRESIDENT AND CEO ISSUES STATEMENT

 MERIS LABS' FORMER PRESIDENT AND CEO ISSUES STATEMENT
 SAN JOSE, Calif., Sept. 21 /PRNewswire/ -- Chris Riedel, former


president and chief executive officer of Meris Laboratories Inc. (NASDAQ: MERS), issued the following statement in response to a press release issued by Meris today:
 "I was disappointed but not surprised by the press release announcing the results of the company's purported investigation. As a part of the settlement agreement reinstating my employment with the company, it was agreed that there would be an investigation into certain allegations made by me regarding improper conduct by certain of the company's officers and directors and whether there had been reasonable grounds for my termination. To that end, a Special Investigative Committee was formed consisting of Henry E. Bose and John E. Swartzberg, M.D., both of whom are members of the board.
 "Prior to rendering their report, however, both Bose and Swartzberg were named as defendants in a shareholders' derivative suit. That action challenged the purported termination of my employment and made some of the same charges relating to the management of Meris that I had previously presented to the Special Committee. The suit also asserts that Swartzberg is guilty of insider trading.
 "Bose and Swartzberg were thus placed in the position of being subject to possible personal liability in the shareholder suit in the event that their investigation exonerated me. To overcome this patent conflict of interest, I made a motion, seconded by the company's other independent board member James Root, for the board to form an independent committee of non-directors to investigate the charges. That motion, however, was voted down, four to two, by the inside directors, all of whom were named as defendants in the shareholders' derivative suit.
 "As a result of all this, I believe that the Special Committee's findings are a whitewash and that the investigation was designed to achieve an erroneous, preordained result. I have publicly stated in the past that as Meris' founder, largest shareholder and Chairman of the Board, I believe the Board of Directors, a majority of which is currently composed of inside directors with inherent conflicts of interest, should be replaced by an independent, outside, shareholder-oriented board. Today's announcement by the company only serves to reinforce this conclusion."
 -0- 9/21/92
 /CONTACT: Chris Riedel, 408-244-2412/
 (MERS) CO: Meris Laboratories ST: California IN: SU:


TM-JG -- SF005 -- 1806 09/21/92 15:34 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 21, 1992
Words:398
Previous Article:MEDI-CAL CONTRACT AWARDED TO EDS
Next Article:/ C O R R E C T I O N -- FOOD LION/


Related Articles
STATEMENT BY CHAIRMAN OF MERIS LABORATORIES
STATEMENT BY CHAIRMAN OF MERIS LABORATORIES
STATEMENT OF CHRIS RIEDEL, FORMER PRESIDENT, CEO OF MERIS LABORATORIES
MERIS ANNOUNCES RECENT EVENTS
STATEMENT FROM CHRIS RIEDEL, FORMER PRESIDENT AND CEO OF MERIS LABORATORIES
STATEMENT FROM FORMER CHAIRMAN AND CEO OF MERIS LABORATORIES, CHRIS RIEDEL, ABOUT MERIS' FINANCIAL RESULTS
Acquisition accounting: SEC closes the GAAP.
Meris Laboratories of San Jose, California Signs Agreement To Sell Its Business and Assets To Unilab Corporation
Meris Laboratories of San Jose, California Closes Sale of Business and Assets To Unilab Corporation.
TARZANA-BASED UNILAB MAKES DEAL TO BUY BANKRUPTED MERIS.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters